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Persistent Contrast Enhancement by Sterically Stabilized
Paramagnetic Liposomes in Murine Melanoma
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Marco Fragai,1,2 Alessandro Franchi,5 Oreste Gallo,6 Cinzia Gavazzi,4 and
Claudio Luchinat1,7
In the present research, we investigated the use of paramagnetic
liposomes as contrast agents (CAs) for the detection of solid
tumors. The liposomeswere sterically stabilized by a polyethylene
glycol (PEG) coating, and their size was constrained to 100 nm.
Dimyristoyl-sn-glycero-3-phosphoethanolamine-N-diethylene-tri-
aminepentaacetate (DMPE-DTPA) was used as the gadolinium-
carrying fatty acid chain. The relaxation properties were charac-
terized through nuclear magnetic relaxation dispersion (NMRD)
measurements, and analyzed with the use of theories and com-
puter programs that are adequate for slowly rotating systems.
Their relaxivity at 1.5 T was found to be acceptable for in vivo use.
We then tested the liposomes against B16-F10murinemelanomas
using standard T1-weighted schemes at 1.5 T, and concentrations
corresponding to 0.03 mmol/kg of gadolinium (i.e., three to six
times lower than the concentration of the small gadolinium com-
plexes in clinical use). The blood half-life was found to be 120 
20 min. The experiments show a good contrast enhancement in
the tumor (33% 22%) 2 hr after administration, a further increase
(43 27%) 20 hr after administration, and a decrease (25% 14%)
54 hr after administration. High persistence of the CA was also
observed in the liver and intestine, as expected in a hepatobiliar
excretion pathway. Magn Reson Med 52:669–672, 2004. © 2004
Wiley-Liss, Inc.
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Magnetic resonance imaging (MRI) plays an important role
in early tumor detection and diagnosis (1,2). Safety, high
spatial resolution, and the ability to obtain a precise ana-
tomical localization of the lesion are among the reasons for
the success of MRI. On the other hand, there are great
difficulties in early tumor detection related to contrast
resolution—for example, small tumors may have the same
signal intensity (SI) as the neighboring tissue. In many
cases, the use of paramagnetic contrast agents (CAs) is
helpful in this respect (1,2). Most CAs in clinical use
consist of small, soluble molecules that can easily cross
the endothelial barrier of blood vessels. However, these
CAs have a short lifetime (1,2) and thus a narrow time
window of optimal contrast enhancement (1,2).
These characteristics may not best exploit the differ-
ences in the vascular properties of tumor tissue with re-
spect to normal tissues. While in normal tissues the tight
barrier formed by the endothelial cells prevents the extrav-
asation of macromolecular CAs from the vessels, in tumor
tissues the leaky vessels may allow the extravasation of
objects hundreds of nanometers in size (3). It has been
proposed (4–6) that the increase in weakness and perme-
ability of the endothelial barrier of the tumor is the key to
developing new macromolecular CAs for tumor diagnosis.
Macromolecular CAs may offer a greater contrast enhance-
ment between the tumor and surrounding tissue, and a
wider diagnostic time window.
With this in mind, we synthesized polyethylene glycol-
stabilized paramagnetic liposomes, characterized them by
nuclear magnetic relaxation dispersion (NMRD), and eval-
uated their capacity to enhance contrast resolution in B16-
F10 melanomas. Polyethylene glycol (PEG) is known to
increase the persistence of liposomes in the bloodstream
(7). Our study demonstrates that liposomes of this type
yield a sizable enhancement and a high persistence in
these tumor lesions, supporting their potential application
in tumor diagnosis.
MATERIALS AND METHODS
Preparation of Liposomes
1-Oleoyl-2-palmitoyl-sn-glycero-3-phosphocholine (OPPC),
1,2-dimyristoyl-sn-glycero-3-phosphoethanolamine-N-
diethylenetriaminepentaacetate (DMPE-DTPA), and 1,2-
dimyristoyl-sn-glycero-3-phosphoethanolamine-N-[me-
thoxy(polyethylene glycol)-2000] (M-PEG-2000-PE) were
purchased from Avanti Polar Lipids, Inc. (Alabaster, AL).
The polycarbonate membranes were purchased from Corn-
ing-Costar (Oneonta, NY). An extrusion device (Lipex Bi-
omembrane, Inc., Vancouver, Canada) was used. Liposomes
consisting of DMPE-DTPA (5 mg, 22% in moles (a higher
percentage of Gd-DTPA on the surface of liposomes was
previously reported (8) to exhibit lower relaxivity)), OPPC
(11.5 mg, 73% in moles) and M-PEG-2000-PE (2.7 mg, 5% in
moles) were prepared as previously described (9). The vesi-
cles were extruded 10 times at 303 K through polycarbonate
membranes of 200 nm and then 100 nm pore size to produce
unilamellar liposomes at a size constrained to 100 nm, as
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previously verified through photon correlation spectroscopy
(9). Diamagnetic liposomes, consisting of OPPC (15 mg) and
M-PEG-2000-PE (2.7 mg, 5% in moles), were used as blanks.
Nuclear Magnetic Relaxation Dispersion Experiments
1H NMRD profiles were collected with the use of Stelar
and Koenig-Brown field cycling relaxometers (10,11) in
the 0.01–50 MHz proton Larmor frequency range at 298 K
and 310 K. The data were analyzed by means of a program
developed by Bertini et al. (12).
Tumor Growth
All experiments were conducted in compliance with the
animal-care regulations set forth in D.L. 116/92. F10-M3
cells, a clone isolated from murine melanoma B16-F10,
cells were kindly provided by Dr. S. Gattoni-Celli (Univer-
sity of South Carolina). The cells were injected subcutane-
ously into the left abdominal flank of 6–8-week-old syn-
geneic C57Bl/6 mice. The animals were routinely moni-
tored to assess the growth of subcutaneous tumors, and
MRI analyses were performed 3 weeks after the tumor cells
were injected. The tumors were 1.5  0.5 cm in diameter.
Histopathology, Immunohistochemistry, and Assessment
of Angiogenesis
To identify the microvessels, we immunostained tissue
sections with a polyclonal antibody against factor VIII
related antigen (Dako Co., Carpinteria, CA) at 1:8 dilution,
using the Nexes immunostainer (Ventana, Tucson, AZ).
Appropriate negative and positive controls were per-
formed. Angiogenesis was evaluated as previously de-
scribed (13). The parameters considered were the mi-
crovessel density (defined as the number of vessel profiles
per square millimeter) and the percentage of field area
(defined as the percentage of positively stained vascular
areas in a field).
Blood Half-life Determination
PEG-coated liposomes were injected into mice, and whole-
blood samples were taken at different times and analyzed
by inductively coupled plasma (ICP) (IRIS Intrepid ICP
Duo; Thermo Electron Corp., Waltham, MA) to determine
the amount of gadolinium.
MRI Scan
A 1.5 T magnet for clinical use (Gyroscan ACS NT; Philips,
Eindhoven, The Netherlands) was used. After a localizer
(scout) scan was performed, the following sequences were
collected: coronal turbo spin echo (TSE) T2-weighted (rep-
etition time (TR) 2000 ms, echo time (TE) 100 ms, TSE
factor 18, 12 slices, number of signal averaging (NSA) 
24, acquisition time  227 s), and coronal and axial spin
echo (SE) T1-weighted (TR  290 ms, TE  20 ms, nine
slices, NSA  10, acquisition time  244 s).
RESULTS
In Vitro Studies
The paramagnetic contribution to the water proton 1H
NMRD profiles of PEG-stabilized paramagnetic liposome
solutions at 298 and 310 K are shown in Fig. 1. Paramag-
netic liposomes, as do general macromolecular conjugates
of gadolinium complexes, exhibit higher relaxivity with
respect to small CAs at fields normally used in imaging (1).
The present profiles are very similar to those obtained in
liposomes that have the same composition but lack
M-PEG-2000-PE (9,14). According to established theories,
we fit the curves in Fig. 1 by taking into account the
presence of static zero field splitting, D (ZFS), and the
modulation of transient zero field splitting, t, with a
correlation time v. The best-fit parameters (see Table 1)
were very similar to those obtained for the same liposomes
without PEG. Apparently, the presence of the polyethyl-
ene glycol chains does not influence the exchange time,
M, which remains the main limiting factor for reaching
high relaxivity at the imaging fields (1,2,9).
The r value indicates that effective averaging of the
metal–water proton dipolar interaction occurs over a
nanosecond time scale. This value is far too short to be the
rotational correlation time of the whole liposomes. As
suggested previously (9), the short value of r could be due
to reorientation of the metal–water proton vector with
respect to the lipid axis, or to free rotation about the bonds
FIG. 1. Water 1H NMRD profiles for solutions of paramagnetic lipo-
somes containing Gd-DMPE-DTPA at 298 K (●) and 310 K (). The
lines represent the best fit curves.
Table 1
Best Fit Parameters From the NMRD Analysis
Parameter/Temperature 298 K 310 K
r, (fixed) 3.0 A˚
t 0.0315 cm
1
r 1.5  10
9 s 1.3  109 s
v 20  10
12 s 11  1012 s
M 1.3  10
6 s 1.2  106 s
D (ZFS) 0.07 cm1
 68 (degrees)
d (fixed) 3.6 A˚
D (diff) 2.2  105 cm2/s 3.2  105 cm2/s
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connecting the diethylenetriaminepentaacetate (DTPA)
moiety to the lipid tail, rather than to rotational diffusion
of the whole (bis)lipid-DTPA adduct on the surface of the
liposome (15). The constancy of M with temperature,
rather than a decrease, is presumably the result of com-
pensation between r, M, v, and D (diff), which are known
to display some degree of covariance in the fit.
In Vivo Studies
We examined nine animals that had been injected 20 days
previously with F10-M3 cells, as described in Materials
and Methods, using both T1- and T2-weighted images ob-
tained before the administration of CA. One animal that
exhibited hyperintense areas in the tumor tissue was ex-
cluded at this stage. Doses of paramagnetic liposomes cor-
responding to 0.030 mmol/kg of gadolinium (one-third the
minimal clinical dose of gadoterate meglumine (Gd-
DOTA)) or gadopentetate dimeglumine (Gd-DTPA) were
injected intravenously into six other mice. The liposomes
were well tolerated, and no adverse effects were observed
during the experiments. Each animal was then serially
scanned with T1-weighted sequences on the coronal and
axial planes at several different times (2 hr, 20 hr, and
54 hr after CA administration). We evaluated the SI by
selecting either the whole tumor area or strips along the
tumor diameters as the region of interest (ROI). Two phan-
toms were used to avoid artifacts related to the autocali-
bration of the instrument, and the tumor data were nor-
malized to the SI of the muscle collected in the same
image. For each mouse, the average of the SI values col-
lected for all slices at each time was calculated. The SI
enhancement was calculated according to

ITumor
IMuscle

Post-contrast
  ITumorIMuscle Pre-contrast
 ITumorIMuscle Pre-contrast   100 [1]
The average enhancements 2, 20, and 54 hr after CA ad-
ministration in six animals are shown in Fig. 2. To com-
pare the enhancements and the kinetics of the paramag-
netic liposomes, we administered 0.1 mmol/kg of Gd-
DTPA dimeglumine to the other two mice of the same
group, and continuously monitored the animals for
30 min, again using T1-weighted sequences on the coronal
and axial planes. In mice injected with paramagnetic lipo-
somes, the tumor area was enhanced an average of 33%
(22%) after 2 hr, 43% (27%) after 20 hr, and 25%
(14%) after 54 hr. This was in striking contrast to the
results with Gd-DTPA (the maximum enhancement (29%)
was achieved after 20 min, and then rapidly disappeared).
In Fig. 3 the images of a mouse before (a) and 20 hr after (b)
the injection are shown. A persistent enhancement is also
observed in the liver, intestine, and kidney, confirming the
FIG. 2. SI enhancement 2 hr, 20 hr, and 54 hr after CA injection. The
values are means  SD from six animals.
FIG. 3. T1-weighted images of a mouse (a) before
and (b) 20 hr after the injection of PEG-stabilized
paramagnetic liposomes.
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biodistribution and elimination pathway previously found
for PEG-stabilized and other long-lived liposomes (5,16–
18).
We assessed the microvessel density of each tumor by
dividing a tumor section into four quadrants and compar-
ing the periphery with the central area. The microvessel
density did not vary significantly across different tumor
regions, while modest differences were observed between
one tumor and another. We then calculated signal en-
hancements in comparable tumor areas obtained within
the same plane. No significant differences were observed
at any time between the tumor periphery and the center.
The distribution of the intensity enhancement appears to
be somewhat inhomogeneous; however, this was not re-
lated to necrotic areas, since their presence was excluded
by T2-weighted images acquired before the liposomes were
injected. The modest variations in microvessel density for
the six tumors showed no significant correlation with the
signal enhancement. On the contrary, a correlation be-
tween tumor size and the signal enhancement was ob-
served (R  0.86).
A different set of animals was injected with the same
dose of PEG-stabilized liposomes, and blood samples were
taken at different times and analyzed for gadolinium by
ICP. The blood half-life was estimated to be 120  20 min,
a value on the same order as previous estimates for similar
PEG-coated liposomes (7).
DISCUSSION AND CONCLUSIONS
As has been widely reported, and was confirmed by our
NMRD analysis, paramagnetic liposomes exhibit a three-
fold higher relaxivity compared to the conventional para-
magnetic complexes Gd-DOTA and Gd-DTPA. Further-
more, the present imaging data show a pronounced and
prolonged SI enhancement of tumor mass with the use of
PEG-stabilized paramagnetic liposomes. The time depen-
dence of the tumor signal enhancement can be qualita-
tively described as a buildup phase on the order of hours,
followed by a very slow decay on the order of days. To-
gether with the information on the blood half-life (2 hr),
this points to a mechanism by which liposomes progres-
sively accumulate in the tumor until liposome circulation
in the blood stream is present, and are then trapped in the
tumor for a much longer time. The accumulation of PEG-
stabilized liposomes into the neoplastic mass was previ-
ously documented in other tumor models (5,7,19).
To understand the high persistence of contrast, one must
consider the histological features of a tumor. Although the
characteristics of the vascular network of a tumor are mod-
ulated by the microenvironment (19), this network usually
consists of immature vessels in which the layer of endo-
thelial cells is deeply altered and the vascular permeabil-
ity is dramatically increased (3). This feature probably
permits the preferential and progressive accumulation of
suitably-sized liposomes (20) into the tumor extracellular
space (4,5).
In contrast, the SI enhancement induced by Gd-DTPA is
lower, and vanishes over a time scale of minutes because
the small and soluble complexes diffuse easily outside the
tumor tissue. Therefore, the use of paramagnetic lipo-
somes in this tumor model allows one to achieve a pro-
longed visualization of neoplastic lesions by exploiting
hystophysiological differences with respect to the neigh-
boring tissue, even without applying a molecular targeting
approach (21).
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